Nation and World Weight management supplements recalled for undeclared ingredients Published: Jul. 03, 2025, 12:03 p.m.

The American College of Cardiology (ACC) recommended GLP-1 drugs for first-line weight management to optimize cardiovascular health. GLP-1 medications are more effective than lifestyle ...

Eli Lilly is a leader in the weight management market, with only a single worthy challenger. The pharmaceutical giant has a robust pipeline and lineup to lead this space over the next five years ...

David Kessler took GLP-1 drugs to help manage his weight. In his new book, he explains why the drugs are revolutionary, but not a panacea.

Letters to the editor: Keep SC beautiful with roadside litter management programs, take responsibility for weight management.

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.

The American College of Cardiology has issued new guidelines recommending weight management medications as first-line treatments for eligible patients. This contrasts with prior guidelines that ...

Integrating digital monitoring, a unique reimbursement model and tailored clinical support, this initiative promotes sustainable weight management and active living to significantly reduce the ...

The American College of Cardiology has issued a Concise Clinical Guidance (CCG) document to aid clinicians in the use of medication for weight management in patients where treatment may provide ...

And when we take into account its pipeline and the recent deals it's made, Novo Nordisk looks even more promising -- the weight-management market is on an incredible growth path.

Some weight management medications may cause bothersome side effects that disrupt daily life, while others can carry the risk of serious, potentially life-threatening side effects.